New Study Raises Questions About Ketamine for Depression
Ketamine's antidepressant benefits are limited, context-dependent, often transient, and require careful clinical oversight and comprehensive treatment plans.
Germany news: Surge in synthetic drugs and opioids DW 10/24/2025
Synthetic drugs, ketamine popularity, and potent new opioids are driving large-scale production, trafficking, and severe overdose risks across Germany.
Ketamine Holds Promise for Cognitive Benefits, Study Shows
Low-dose ketamine induces neuroplasticity, treats refractory depression rapidly, and shows potential to improve cognitive deficits in neurological and psychiatric disorders.
Ketamine deaths up twenty-fold since 2014 as experts issue drug mixing warning
Illicit ketamine-related deaths in England, Wales, and Northern Ireland have soared, driven by increasing polydrug use, prompting calls for reclassification.
Jim Irsay suffered repeated painkiller relapses and overdoses since 2020, received ketamine treatment, and died May 21 amid ongoing addiction struggles.
'Ketamine Queen' to plead guilty to federal charges, selling drug that killed Matthew Perry
Jasveen Sangha, known as the 'Ketamine Queen,' has agreed to plead guilty to federal charges related to distributing ketamine that led to the death of actor Matthew Perry.
The Vivienne hid ketamine struggle 'to protect family'
Acknowledging addiction and breaking the stigma around it is essential for prevention and support. The Vivienne's story highlights the hidden struggles many face.